Direct labeling of virus particles is a powerful tool for the visualization of virus-cell interaction events. However, this technique involves the chemical modification of viral proteins that affects viral biological properties. Here we describe an alternative approach of influenza virus labeling that utilizes Function-Spacer-Lipid (FSL) constructs that can be gently inserted into the virus membrane. We assessed whether labeling with fluorescent (fluo-Ad-DOPE) or biotin-labeled (biot-CMG2-DOPE) probes has any deleterious effect on influenza virus hemagglutinin (HA) receptor specificity, neuraminidase (NA) activity, or replicative ability in vitro. Our data clearly show that neither construct significantly affected influenza virus infectivity or viral affinity to sialyl receptors. Neither construct influenced the NA activities of the influenza viruses tested, except the A/Puerto Rico/8/34 (H1N1) strain. Our data indicate that lipid labeling provides a powerful tool to analyze influenza virus infection in vitro.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Blake D, Bovin N, Bess D, Henry S. 2011. FSL constructs: a simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability. J Vis Exp, 54:e3289.
Bovin N V, Korchagina E Y, Zemlyanukhina T V, Byramova N E, Galanina O E, Zemlyakov A E, Ivanov A E, Zubov V P, Mochalova L V. 1993. Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J, 10:142–151.
Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72:248–254.
Ewers H., Schelhaas M. 2012. Analysis of virus entry and cellular membrane dynamics by single particle tracking. In: Methods in Enzymology, 506:63–80.
Fecek R J, Busch R, Lin H, Pal K, Cunningham C A, Cuff C F. 2006. Production of Alexa Fluor 488-labeled reovirus and characterization of target cell binding, competence, and immunogenicity of labeled virions. J Immunol Methods, 314:30–37.
Frame T, Carroll T, Korchagina E, Bovin N, Henry S. 2007. Synthetic glycolipid modification of red blood cell membranes. Transfusion, 47:876–882.
Freistadt M S, Eberle K E. 2006. Fluorescent poliovirus for flow cytometric cell surface binding studies. J Virol Methods, 134:1–7.
Georgakopoulos T, Komarraju S, Henry S, Bertolini J. 2012. An improved Fc function assay utilizing CMV antigen-coated red blood cells generated with synthetic function-spacer-lipid constructs. Vox Sanguinis, 102:72–78.
Hadac E, Federspiel M, Chernyy E, Tuzikov A, Korchagina E, Bovin N, Russell S, Henry S. 2011. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. J Virol Methods, 176:78–84.
Henry S. 2009. Modification of red blood cells for laboratory quality control use. Curr Opin Hematol, 16:467–72.
Hult A K, Frame T, Chesla S, Henry S, Olsson M L. 2012. Flow cytometry evaluation of red blood cells mimicking naturally occurring ABO subgroups after modification with variable amounts of function-spacer-lipid A and B constructs. Transfusion, 52:247–251.
Ilyushina N A, Govorkova E A, Gray T E, Bovin N V, Webster R G. 2008. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog, 4:e1000043.
Korchagina E, Tuzikov A, Formanovsky A, Popova I, Henry S, Bovin N. 2012. Towards creating cell membrane glyco-landscapes with glycan lipid constructs. Carbohydr Res, 356:238–246.
Lakadamyali M, Rust M J, Babcock H P, Zhuang X. 2003. Visualizing infection of individual influenza viruses. Proc Natl Acad Sci USA, 100:9280–9285.
Matrosovich M, Matrosovich T, Gray T, Roberts N, Klenk H. 2004. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol, 78:12665–12667.
Matrosovich M N, Gambaryan A S, Tuzikov A B, Byramova N E, Mochalova L V, Golbraikh A A, Shenderovich M D, Finne J, Bovin N V. 1993. Probing of the receptor-binding sites of the H1 and H3 influenza virus hemagglutinins by synthetic and natural sialosides. Virology, 196:111–123.
Metzner C, Kochan F, Dangerfield J A. 2013. Fluorescence molecular painting of enveloped viruses. Mol Biotechnol, 53:9–18.
Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, Katinger H, Egorov A, Bovin N. 2003. Receptorbinding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology, 313:473–480.
Nichols J E, Mock D J, Roberts Jr N J. 1992. Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes. Arch Virol, 130:441–455.
Oliver C, Blake D, Henry S. 2011. In vivo neutralization of anti-A and successful transfusion of A antigen-incompatible red blood cells in an animal model. Transfusion, 51:2664–2675.
Potier M, Mameli L, Belisle M, Dallaire L, Melancon S. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem, 94:287–296.
Reed L J, Muench H. 1938. A simple method for estimating fifty percent endpoints. Am J Hyg, 27:493–497.
Ruigrok R, Andree P, Hooft van Huysduynen R, Mellema J. 1984. Characterization of three highly purified influenza virus strains by electron microscopy. J Gen Virol, 65:799–802.
Rust M J, Lakadamyali M, Zhang F, Zhuang X. 2004. Assembly of endocytic machinery aroung individual influenza viruses during viral entry. Nat Struct Mol Biol, 11:567–573.
Suzuki T, Takahashi T, Saito T, Guo C T, Hidari K I, Miyamoto D, Suzuki Y. 2004. Evolutional analysis of human influenza A virus N2 neuraminidase genes based on the transition of the low-pH stability of sialidase activity. FEBS Lett, 557:228–232.
Wagner R, Matrosovich M, Klenk H. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol, 12:159–166.
Wright P F, Neumann G, Kawaoka Y. 2006. Orthomyxoviruses In: Knipe D M, Howley P M (eds), Fields Virology, 5th ed, Philadelphia: Lippincott Williams and Wilkins, pp1641–1740.
Yoshimura A, Ohnishi S. 1984. Uncoating of influenza virus in endosomes. J Virol 51:497–504.
Zhang S L, Tan H, Hanson B J, Ooi E E. 2010. A simple method for Alexa Fluor dye labelling of dengue virus. J Virol Methods, 167:172–177.
These authors contributed equally to this work.
About this article
Cite this article
Ilyushina, N.A., Chernyy, E.S., Korchagina, E.Y. et al. Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids. Virol. Sin. 29, 199–210 (2014). https://doi.org/10.1007/s12250-014-3475-1
- Function-Spacer-Lipid (FSL) constructs
- labeling of influenza viruses
- synthetic lipids